CHARMERUK Medical Research CouncilHealth Research AuthoritymedicineWales 2 Research Ethics Committee
…ervention to increase proactive deprescribing in hospitals. The CHARMER intervention comprises a deprescribing action plan, deprescribi…
Entity family
Programmes, procedures, policies, and other actions being evaluated. Examples include screening, surgery, public-health programmes.
This intervention is selected. Its supporting articles are shown below.
…ervention to increase proactive deprescribing in hospitals. The CHARMER intervention comprises a deprescribing action plan, deprescribi…
…s’ and pharmacists’ barriers and enablers to deprescribing. The CHARMER definitive trial will evaluate effectiveness, cost-effectivenes…